Fig 4 -

Fig 4 -

<div><p>Coinfection with human papillomavirus (HPV) and HIV compounds the risks of developing cervical, anal, and HPV-associated oral neoplasia. Safe prophylactic vaccines are available to prevent HPV infections in people with HIV(PWH). Yet, vaccine efficacy and duration of protection re...

Full description

Saved in:
Bibliographic Details
Main Author: Alvine M. Akumbom (20460907) (author)
Other Authors: Alanna J. Bergman (14551967) (author), Howard Strickler (4510189) (author), Chakra Budhathoki (4333303) (author), Manka Nkimbeng (9916716) (author), Raeven Grant (20460910) (author), Nancy R. Reynolds (9692588) (author), Kawsar R. Talaat (9721230) (author)
Published: 2024
Subjects:
Medicine
Biotechnology
Immunology
Cancer
Science Policy
Infectious Diseases
Virology
Computational Biology
xlink "> coinfection
hedges &# 8217
applying existing evidence
43 ), respectively
hpv vaccine trials
safe prophylactic vaccines
random effects meta
protection remain questionable
prevent hpv infections
meaningful clinical outcomes
hpv18 seropositivity cut
associated oral neoplasia
hpv vaccine efficacy
people without hiv
analysis </ p
vaccine efficacy
persistent infections
oral lesions
systematic review
significantly lower
sexual debut
sex differences
secondary outcome
risk factors
qualitatively synthesized
people living
mean difference
included enrollees
human papillomavirus
hpv18 genotypes
hiv compounds
early age
defining illness
cell count
baseline cd4
assuming milli
assess age
500 cells
400 copies
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items